Navigation Links
SL Industries Names Louis J. Belardi Chief Financial Officer
Date:9/2/2010

MT. LAUREL, N.J., Sept. 2 /PRNewswire-FirstCall/ --  SL Industries, Inc. (Amex: SLI) ("SLI" or the "Company") announced today that Louis J. Belardi has been named Chief Financial Officer, Secretary, and Treasurer of the Company, effective August 30, 2010.

"I am pleased to promote Lou to the CFO position at SLI," said William Fejes, Chief Executive Officer of the Company.  "Lou has been a key member of the SLI management team in his position as Corporate Controller since 2004.  His years of experience at SLI combined with his strong career experience in finance and administration make him uniquely qualified to step into the CFO job and play an important part in the future success of the Company. "

Prior to joining SL Industries in 2004, Mr. Belardi was a partner in his own management consulting firm that specialized in providing financial consulting to public corporations.  Before entering consulting, he was promoted through several financial roles to the position of Vice President Finance and Administration at Aydin Corporation, now part of L-3 Communications.  He also held finance positions in businesses in the health care and energy services industries.  Mr. Belardi started his career at Price Waterhouse.  He is a CPA and holds a Bachelor of Science degree from the University of Scranton and a Master's Degree in Finance from Temple University Graduate School.

About SL Industries

SL Industries, Inc. designs, manufactures and markets power electronics, power motion, power protection, teleprotection and communications equipment and systems that are used in a variety of medical, aerospace, computer, datacom, industrial, telecom, transportation and electric power utility equipment applications. For more information about SL Industries, Inc. and its products, please visit the Company's web site at www.slindustries.com.

Forward-Looking Statements

This press release contains statements that are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on current expectations, estimates and projections about the Company's business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors, including the following: the effectiveness of the cost reduction initiatives undertaken by the Company, changes in demand for the Company's products, product mix, the timing of customer orders and deliveries, the impact of competitive products and pricing, constraints on supplies of critical components, excess or shortage of production capacity, difficulties encountered in the integration of acquired businesses and other risks discussed from time to time in the Company's filings and reports with the Securities and Exchange Commission. In addition, such statements could be affected by general industry and market conditions and growth rates, and general domestic and international economic conditions. Such forward-looking statements speak only as of the date on which they are made, and the Company does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this release.Contact:Louis BelardiPhone: 856-727-1500Facsimile: 856-727-1683
'/>"/>

SOURCE SL Industries, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Roper Industries Announces Senior Subordinated Convertible Notes Due 2034 to Accrue Contingent Cash Interest and Conversion Rate Adjustment
2. Roper Industries Schedules Fourth Quarter 2009 Financial Results Conference Call
3. Roper Industries Announces Senior Subordinated Convertible Notes Due 2034 to Accrue Contingent Cash Interest
4. Roper Industries Completes the Acquisition of Verathon, Inc.
5. Roper Industries Announces Two Acquisitions to Enhance Growth in Medical and Toll & Traffic Businesses
6. Lilly to Sell Tippecanoe Manufacturing Site to Evonik Industries
7. Prix Galien USA Honors Innovation in Science and Biotech Industries
8. Neptune Industries Reports Favorable Phase II Trial Results on Ento- Protein(TM)
9. BayCare Health System Names Tim Thompson Chief Information Officer
10. Watson Names Sigurdur Oli Olafsson Executive Vice President, Global Generics
11. K-V Pharmaceutical Names Thomas McHugh Chief Financial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)...  Aethlon Medical, Inc. (Nasdaq: AEMD ), ... treat life-threatening diseases, today announced results for the ... 2015. --> --> ... our last quarterly call, we strategically advanced pre-clinical ... to establish the Aethlon Hemopurifier® as a leading ...
(Date:2/4/2016)... , Feb. 4, 2016  AMRI (NASDAQ:  AMRI) today announced ... Pfizer Inc. and President of Pfizer Global Supply, has been ... February 4, 2016. In addition, the Company announced that Mr. ... audit committee since 2010, has retired from the AMRI Board ... to his other business ventures.  William S. ...
(Date:2/4/2016)... -- --> --> ... Automated External Defibrillator (AED) Market by Product (Semi-Automated External ... Hospitals, Homecare & Nursing Homes) - Forecast to 2019", ... and segments the concerned market with an analysis and ... grow to about $367.0 million by 2019, at a ...
Breaking Medicine Technology:
(Date:2/5/2016)... ... February 05, 2016 , ... ... stage for new clinical and scientific initiatives have all marked the last 12 ... appointed President and CEO of the nation’s oldest cancer center, Candace S. Johnson, ...
(Date:2/5/2016)... Rosa, CA (PRWEB) , ... February 05, 2016 ... ... pleased to announce the addition of micro-needling services in their Napa Valley office. ... The founders of Plastic Surgery Associates, Dr. Canales and Dr. Furnas, are part ...
(Date:2/5/2016)... Toronto, Ontario (PRWEB) , ... February 05, 2016 , ... ... the Scarborough General Hospital Burn Unit, plastic and cosmetic surgeon Dr. Wayne Carman transitioned ... the Scarborough Hospital. He successfully completed his first three-year term as chief and began ...
(Date:2/5/2016)... (PRWEB) , ... February 05, 2016 , ... ... independent PROSHRED franchises from across the country gathered at the La Valencia Hotel ... top performers. PROSHRED Chicago was named the year’s most outstanding franchise, walking ...
(Date:2/5/2016)... ... , ... Give To Cure today announced that it is working ... To Cure’s campaign that is crowdfunding clinical trials to help find cures faster for ... a smart device. In 2015 alone, Venmo processed $7.5 billion in transactions among users. ...
Breaking Medicine News(10 mins):